As of 2026-03-26, the EV/EBITDA ratio of BioLife Solutions Inc (BLFS) is 92.68. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLFS's latest enterprise value is 923.47 mil USD. BLFS's TTM EBITDA according to its financial statements is 9.96 mil USD. Dividing these 2 quantities gives us the above BLFS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 20.7x | 16.0x |
| Forward P/E multiples | 14.2x - 19.9x | 16.6x |
| Fair Price | 3.51 - 4.85 | 3.94 |
| Upside | -82.2% - -75.4% | -80.0% |
| Date | EV/EBITDA |
| 2026-03-25 | 93.46 |
| 2026-03-24 | 92.68 |
| 2026-03-23 | 90.11 |
| 2026-03-20 | 88.56 |
| 2026-03-19 | 91.86 |
| 2026-03-18 | 89.87 |
| 2026-03-17 | 91.23 |
| 2026-03-16 | 89.68 |
| 2026-03-13 | 86.18 |
| 2026-03-12 | 85.17 |
| 2026-03-11 | 89.34 |
| 2026-03-10 | 87.69 |
| 2026-03-09 | 93.65 |
| 2026-03-06 | 93.46 |
| 2026-03-05 | 94.72 |
| 2026-03-04 | 97.38 |
| 2026-03-03 | 94.96 |
| 2026-03-02 | 106.35 |
| 2026-02-27 | 114.49 |
| 2026-02-26 | 106.16 |
| 2026-02-25 | 106.11 |
| 2026-02-24 | 106.98 |
| 2026-02-23 | 108.10 |
| 2026-02-20 | 109.11 |
| 2026-02-19 | 109.79 |
| 2026-02-18 | 107.90 |
| 2026-02-17 | 105.57 |
| 2026-02-13 | 104.94 |
| 2026-02-12 | 101.79 |
| 2026-02-11 | 105.04 |
| 2026-02-10 | 106.98 |
| 2026-02-09 | 106.88 |
| 2026-02-06 | 105.91 |
| 2026-02-05 | 103.93 |
| 2026-02-04 | 107.08 |
| 2026-02-03 | 107.90 |
| 2026-02-02 | 105.43 |
| 2026-01-30 | 102.86 |
| 2026-01-29 | 106.64 |
| 2026-01-28 | 108.39 |
| 2026-01-27 | 118.28 |
| 2026-01-26 | 118.08 |
| 2026-01-23 | 117.74 |
| 2026-01-22 | 123.12 |
| 2026-01-21 | 121.04 |
| 2026-01-20 | 117.21 |
| 2026-01-16 | 115.56 |
| 2026-01-15 | 115.80 |
| 2026-01-14 | 114.93 |
| 2026-01-13 | 113.04 |